Two of the most-requested repair-model compounds, compared on mechanism, stability and the analytical complications that come with pre-blended vials.
BPC-157 and TB-500 are frequently discussed together, which obscures the fact that they act through entirely different cellular machinery. Treating them as interchangeable produces muddled study design.
| Compound | Class | Primary mechanism studied | Stability profile |
|---|---|---|---|
| BPC-157 | Pentadecapeptide fragment | Angiogenic signalling and growth-factor receptor upregulation | Comparatively robust; short sequence |
| TB-500 | Thymosin β4 fragment | Actin sequestration and cell migration | Robust lyophilised; aliquot after reconstitution |
Why blended vials need extra scrutiny
A pre-blended repair vial is convenient but analytically awkward: a single HPLC trace of a two-peptide mixture cannot cleanly resolve the purity of each component unless the method is developed for it. Vitality Labs documents blends by publishing the certificate for each constituent lot as well as the blend ratio, so nothing is hidden behind a combined peak.
Practical bench considerations
- Match the compound to the mechanism you are actually measuring — migration assays and angiogenesis assays are not the same experiment
- Blends remove your ability to vary one variable independently
- Record lot codes for both constituents when using a blended vial
- Reconstitute with bacteriostatic water and aliquot immediately for multi-day protocols
Frequently asked
Should a study use a blend or single compounds?
For mechanistic work, single compounds. Blends suit protocols where the combined condition itself is the variable being observed.
How does Vitality Labs verify blend ratios?
Constituent lots are individually certified before blending, and the blend ratio is recorded against the finished lot code published on our Lab Results page.
